Skip to main content
. Author manuscript; available in PMC: 2023 Apr 5.
Published in final edited form as: Contemp Clin Trials. 2015 May 21;43:114–119. doi: 10.1016/j.cct.2015.05.011

Table 1.

List of research measures, research assessment constructs, and research measurement time points.

Measure Type Construct assessed Time points
ADIS-5 CS Diagnosis and severity for affective disorders BL, PT, FU
Background SR Demographic variables and military history BL
Chart review CS Physical health conditions, medications, healthcare utilization BL, FU
TBI screener SR History of traumatic brain injury and related symptoms BL
APPQ SR Symptoms of agoraphobia, social anxiety, and interoceptive avoidance BL, PT, FU
DASS SR Symptoms of depression, anxiety, and stress BL, BWS, PT, FU
IIRS SR Impairment related to symptoms of depression and anxiety BL, BWS, PT, FU
MASA SR Symptoms of avoidance, anhedonia, impairment, and coping with substance use BL, PT, FU
PCL-5 SR Symptoms of intrusions, avoidance, numbing, and arousal BL, PT, FU
STICSA-Trait SR Symptoms of cognitive and somatic anxiety BL, BWS, PT, FU
SF-36V SR Physical and mental health symptoms and related impairment BL, PT, FU
STTS-R SR Satisfaction with therapy and therapist PT, FU

Note. ADIS-5 = Anxiety Disorder Interview Schedule for the DSM-5; TBI = traumatic brain injury; APPQ = Albany Panic and Phobia Questionnaire; DASS = Depression Anxiety Stress Scales; IIRS = Illness Intrusiveness Rating Scale; MASA = Multidimensional Assessment of Social Anxiety; PCL-5 = PTSD Checklist for DSM-5; STICSA-Trait = State Trait Inventory for Cognitive and Somatic Anxiety — Trait Version; SF-36V = Veterans Short-Form Health Survey; STTS-R = Satisfaction with Therapy and Therapist Scale; CS = clinician scored; SR = self-report; BL = baseline; BWS = biweekly sessions (1, 3, 5, 7, 9, and 11); PT = post-treatment; FU = follow-up.